Bharat Biotech announces COVAXIN capacity expansion EP News Bureau Apr 20, 2021 Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for COVAXIN
US, India lead in COVID-19 clinical trials benefitted by large patient pools: GlobalData EP News Bureau Apr 8, 2021 The US saw 823 COVID-19 trials in March, followed by India at 491